The Beth Pathology 201 Lyons Ave BLDG EL, Newark, NJ 07112 9739267307 (phone), 9737058301 (fax)
Jersey City Medical Center Pathology Laboratory 355 Grand St STE 3, Jersey City, NJ 07302 2019152486 (phone), 2019152377 (fax)
Education:
Medical School Tianjin Med Univ, Tianjin City, Tianjin, China Graduated: 1988
Languages:
English
Description:
Dr. Lin graduated from the Tianjin Med Univ, Tianjin City, Tianjin, China in 1988. She works in Jersey City, NJ and 1 other location and specializes in Anatomic Pathology & Clinical Pathology. Dr. Lin is affiliated with Jersey City Medical Center and Newark Beth Israel Medical Center.
Syed Faiyaz Ahmed Hossainy - Hayward CA, US Yiwen Tang - San Jose CA, US Homayon Askaryar - Newark CA, US Qing Lin - Hayward CA, US Thierry Glauser - Redwood City CA, US
Assignee:
Advanced Cardiovascular Systems, Inc. - Santa Clara CA
International Classification:
A61F 2/82
US Classification:
424423
Abstract:
Methods for making coatings on an implantable device such as a drug-eluting stent comprising a polymer and nano or microparticles of a drug in slow-dissolving polymorph, implantable devices produced by the methods and methods of using the coatings are provided.
Jane Guo Shiah - Irvine CA, US Qing Lin - Fremont CA, US
International Classification:
A61K 47/34
US Classification:
264145
Abstract:
Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.
- Irvine CA, US James Jane-Guo Shiah - Irvine CA, US Qing Lin - Fremont CA, US
International Classification:
A61K 9/00 A61K 31/573 A61K 47/34 A61K 31/57
Abstract:
Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.
- Irvine CA, US James Jane-Guo Shiah - Irvine CA, US Qing Lin - Fremont CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 9/00 A61K 47/34 A61K 31/573
Abstract:
Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.
th experiments employ a multiton volume of liquid xenon. Qing Lin of the University of Science and Technology of China and member of the PandaX Collaboration says that the result is an extremely important validation of the experiment. Detecting such a rare signal proves our ability to detect a dark
Date: Nov 07, 2024
Category: Science
Source: Google
PandaX sets new constraints on the search for light dark matter via ionization signals
"Currently, strong constraints exist for heavy mass dark matter candidates derived from null results in direct detection experiments using xenon detectors," Yue Meng, Qing Lin and Ning Zhou told Tech Xplore, on behalf of the PandaX collaboration. "However, traditional searches are not sensitive to l